#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	12662	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2252	559.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	686	C,T	645,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22990	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3460	661.6	0	.	n	.	0	T695C	SNP	695	695	T	959	959	C	693	C	662	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22990	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3460	661.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1601	1601	A	730	A	684	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22990	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3460	661.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2235	2235	C	779	C	728	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22990	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3460	661.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2309	2309	A	724	A,G	675,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22990	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3460	661.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2861	2861	C	731	C	689	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1726	folP	852	852	100.0	folP.l15.c30.ctg.1	1475	116.7	1	SNP	p	R228S	1	.	.	682	684	AGC	1015	1017	AGC	194;190;191	A;G;C	184;181;182	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4326	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3453	124.9	1	SNP	p	S91F	0	.	.	271	273	TCC	620	622	TCC	156;157;159	T;C;C	147;148;151	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4326	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3453	124.9	1	SNP	p	D95G	0	.	.	283	285	GAC	632	634	GAC	153;153;153	G;A;C	142;144;140	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4326	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3453	124.9	1	SNP	p	D95N	0	.	.	283	285	GAC	632	634	GAC	153;153;153	G;A;C	142;144;140	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1268	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1470	86.2	0	.	p	.	0	A39T	NONSYN	115	117	GCC	548	550	ACC	143;142;142	A;C;C	133;135;135	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1268	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1470	86.2	0	.	p	.	0	R44H	NONSYN	130	132	CGC	563	565	CAC	140;142;144	C;A;C	136;135;138	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1268	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1470	86.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	746	748	CAC	173;172;170	C;A;C	164;161;160	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1268	mtrR	633	633	99.21	mtrR.l6.c30.ctg.1	1470	86.2	1	SNP	p	G45D	0	.	.	133	135	GGC	566	568	GGC	147;149;151	G,T;G;C	138,1;141;143	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	728	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1048	69.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4490	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	153.1	1	SNP	p	D86N	0	.	.	256	258	GAC	573	575	GAC	192;193;193	G;A;C	181;178;182	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4490	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	153.1	1	SNP	p	S87R	0	.	.	259	261	AGT	576	578	AGT	194;194;192	A;G;T	181;183;180	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4490	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	153.1	1	SNP	p	S87W	0	.	.	259	261	AGT	576	578	AGT	194;194;192	A;G;T	181;183;180	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4490	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	153.1	1	SNP	p	S87I	0	.	.	259	261	AGT	576	578	AGT	194;194;192	A;G;T	181;183;180	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4490	parC	2304	2304	100.0	parC.l6.c30.ctg.1	2924	153.1	1	SNP	p	S88P	0	.	.	262	264	TCC	579	581	TCC	190;190;190	T;C;C	181;177;175	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3878	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2669	145.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1560	1562	GGC	212;209;210	G;G;C	197;193;195	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1259	1261	GCA	204;204;202	G;C;A	184;183;184	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1262	1264	ATC	205;206;204	A;T;C	186;187;187	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1274	1276	GTG	197;200;200	G;T;G	180;184;183	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1274	1276	GTG	197;200;200	G;T;G	180;184;183	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1778	1780	ACC	154;153;153	A;C;C	147;149;151	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1832	1834	GCG	145;146;145	G;C,G;G	135;118,1;129	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1832	1834	GCG	145;146;145	G;C,G;G	135;118,1;129	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1955	1957	GGC	162;160;162	G;G;C	152;149;149	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1964	1966	GGC	155;150;151	G;G;C	142;138;139	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3320	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2431	136.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1982	1984	CCG	122;124;124	C,G;C,G;G,GGC	88,4;91,1;92,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4906	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3186	153.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1914	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1811	105.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	466	466	C	124	C	116	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	0	.	p	.	0	I45V	NONSYN	133	135	ATT	593	595	GTT	196;193;192	G;T,G;T	184;177,1;180	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	0	.	p	.	0	I75V	NONSYN	223	225	ATT	683	685	GTT	198;196;195	G;T;T	184;179;181	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	0	.	p	.	0	S89T	NONSYN	265	267	AGC	725	727	ACC	179;179;181	A;C;C	154;165;169	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	0	.	p	.	0	I98V	NONSYN	292	294	ATC	752	754	GTC	179;178;179	G;T;C	163;163;168	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	0	.	p	.	0	F310L	NONSYN	928	930	TTC	1388	1390	CTC	207;205;204	C,T;T,G;C	192,1;190,1;192	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	1	SNP	p	G120K	1	.	.	358	360	AAG	818	820	AAG	186;182;183	A;A;G	176;174;175	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	1	SNP	p	A121N	1	.	.	361	363	AAC	821	823	AAC	180;178;175	A;A;C	176;174;173	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2484	porB1b	1038	1038	99.42	porB1b.l15.c17.ctg.1	1624	151.5	1	SNP	p	N121D	0	.	.	361	363	AAC	821	823	AAC	180;178;175	A;A;C	176;174;173	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9228	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4747	193.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1915	1917	AAT	220;221;218	A;A;T	209;210;207	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1054	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1048	100.2	1	SNP	p	V57M	1	.	.	169	171	ATG	588	590	ATG	217;217;220	A;T;G	209;209;213	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
